Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. - Wikidata - awgldk - TriplyDB

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.

http://www.wikidata.org/entity/Q37187727

about

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients Emerging methods for disease monitoring in malignant gliomas Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.QuantitativeT2: interactive quantitative T2 MRI witnessed in mouse glioblastoma.Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: a case report.On the selection of sampling points for myocardial T1 mapping Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas Quantitative MR Imaging of Brain Tissue and Brain Pathologies.The Clinical Significance of Ependymal Enhancement at Presentation in Patients with Malignant Glioma An Update on the Approach to the Imaging of Brain Tumors.Quantitative MRI for analysis of peritumoral edema in malignant gliomas Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?Ultrafast compartmental relaxation time mapping with linear algebraic modeling.Ultrafast compartmentalized relaxation time mapping with linear algebraic modeling.MR Fingerprinting of Adult Brain Tumors: Initial Experience.Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.Survival prediction in high-grade gliomas using CT perfusion imaging.Differentiation between vasogenic edema and infiltrative tumor in patients with high-grade gliomas using texture patch-based analysis.Improved visibility of brain tumors in synthetic MP-RAGE anatomies with pure T1 weighting.How treatment monitoring is influencing treatment decisions in glioblastomas.IVIM analysis of brain tumors: an investigation of the relaxation effects of CSF, blood, and tumor tissue on the estimated perfusion fraction.Manganese-enhanced MRI of minimally gadolinium-enhancing breast tumors.Edge Contrast of the FLAIR Hyperintense Region Predicts Survival in Patients with High-Grade Gliomas following Treatment with Bevacizumab

P2860

Q26853308-288EFD8C-9345-4DD5-B10E-80C2F849AB24 Q27023823-DA2B9DCB-354E-460D-BCC4-519F71FD00AC Q30907831-EB24F2F5-88DB-450A-9CE5-ED6515CC22B7 Q30982807-7D2EA8AB-CCF2-4928-93A2-C834413DF146 Q33684824-775A1488-22C9-40ED-B3C1-AC2C4D41933B Q34466204-4172626B-09CB-48D0-A495-59E299266764 Q34807753-EDC14350-7423-4378-86C7-03C38DB0D2EE Q35724467-DDC5DD53-33B9-4F05-8F59-5F329717CF01 Q36218456-DE036FF1-EB22-448A-ACA3-978B40ACF4D1 Q36374577-2C3AD99A-0208-4DED-B6FD-FB27FB20ECCA Q36380888-24CE346B-0E3C-4B90-B6D3-5CC66F5834C4 Q38635290-F9D9388D-B9F1-4126-B248-CB6052114CAE Q38638044-C90A37D1-A276-4D81-9A64-739A24C0233B Q38841037-1ECDD883-8752-44E5-9F05-8B2A22B71A37 Q40402415-EE1412A9-721E-4A5D-B901-D7135D21D169 Q40979569-12744E10-961D-4018-84B2-647CB3C00D59 Q41090603-E6CFF7D8-5C56-4B4F-980F-41A51A559B18 Q47191350-FE3F5ED6-4B12-4ADB-A0D5-63E4E6A1F61B Q48184512-8F1F7855-31D9-4B4E-8F47-F1CFD10BADDE Q48292017-6544D42E-2A74-4D8A-8644-A9632E371E8B Q48423696-B7E7975A-205A-41A9-96EC-558BD341DC35 Q53076779-AB2004BE-E6DD-4CD0-896F-C0E0520D2A53 Q57739391-90BBB776-E041-4DF7-B4CF-35D19029B56C

P2860

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.

http://www.wikidata.org/entity/Q37187727

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Quantitative T2 mapping of rec ...... and predicts overall survival.

@en

Quantitative T2 mapping of rec ...... and predicts overall survival.

@nl

type

label

Quantitative T2 mapping of rec ...... and predicts overall survival.

@en

Quantitative T2 mapping of rec ...... and predicts overall survival.

@nl

prefLabel

Quantitative T2 mapping of rec ...... and predicts overall survival.

@en

Quantitative T2 mapping of rec ...... and predicts overall survival.

@nl

P1433

Q37187727-311DBB53-A744-4555-85B4-7CC77819ED38

P1476

Q37187727-EA7CC4BE-C7F7-4042-BA41-9AB7EE33B0CD

P2093

Q37187727-5262359A-4A62-4934-AD13-6B0AD95BA833

Q37187727-5D5C4A2D-4C24-4BF4-B1B5-953A7D8B0CA1

Q37187727-6F8B92B0-BAF3-4C2D-83EA-AA1A9F0C05A6

Q37187727-8D162849-865E-4BD6-AA01-2C2E5819FDA6

Q37187727-DB435232-8E1E-4BBB-BBF5-C78D8CF19EE5

Q37187727-FB0AF8F7-CEF9-4E79-A613-B9DBC637A41A

P2860

Q37187727-02FD1D51-68A1-4132-A63B-FF792697D182

Q37187727-05B4D46F-C912-4222-AFF8-82147449E468

Q37187727-07E1E53E-F42D-4475-9BB7-C8A3225135E2

Q37187727-161CAFBE-3888-4E9D-822D-701A2C315CE5

Q37187727-194C53C8-8B97-462A-9492-C6040E5C4874

Q37187727-2C3CC973-82E5-410A-8E74-8AE4627BAE1B

Q37187727-2EA7C8C7-BFFD-4160-8F45-8024883B0817

Q37187727-4F56B8F6-5CAE-4D51-A33C-0EB78B4469D6

Q37187727-6A8ED203-E515-4156-8ACB-30B04E4B3EFA

Q37187727-6AC1CCAD-1B8E-4B83-998F-BB6A8882CF7B

P304

Q37187727-BDBB0D25-4E1B-4C8E-8866-3DF94F31945A

P31

Q37187727-CEB663FF-51A5-468B-A601-7713456A155D

P356

Q37187727-53664928-A1C4-48B1-BB0E-F13DFB7F58A3

P433

Q37187727-47DA88D4-7EFB-42AF-8288-68C3B4309133

P478

Q37187727-BDB599A7-D905-4EB6-A3BB-65F69F671A10

P50

Q37187727-53ED4B13-7D92-4C98-801E-047DBB915847

P577

Q37187727-FBEA62FB-A4C2-4DDB-9469-9EB6FCF36AE6

P5875

Q37187727-94790ADF-8722-417C-A9F8-503E4762C0A2

P698

Q37187727-8B8E2EA2-C0C5-4FC4-B4E6-021C14BFE6D6

P921

Q37187727-A715DA48-AC74-4AA2-BCE4-10F63E357D75

P932

Q37187727-03010844-42FE-4530-A639-999167B78626

P356

P1433

P1476

Quantitative T2 mapping of rec ...... and predicts overall survival.

@en

P2093

Alina Jurcoane

http://www.w3.org/2001/XMLSchema#string

Elke Hattingen

http://www.w3.org/2001/XMLSchema#string

Joachim P Steinbach

http://www.w3.org/2001/XMLSchema#string

Keivan Daneshvar

http://www.w3.org/2001/XMLSchema#string

Oliver Bähr

http://www.w3.org/2001/XMLSchema#string

Ulrich Pilatus

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

In vivo NMR T2 relaxation of experimental brain tumors in the cat: a multiparameter tissue characterization.

Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.

Pseudoprogression and pseudoresponse in the treatment of gliomas.

Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma.

Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields.

Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma

P304

1395-1404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOT105

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Michel Mittelbronn

P577

2013-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255706587

http://www.w3.org/2001/XMLSchema#string

P698

23925453

http://www.w3.org/2001/XMLSchema#string

P921

P932

3779046

http://www.w3.org/2001/XMLSchema#string